CollPlant Biotechnologies Ltd (CLGN): Next-Year EPS Estimate 69.18%
As of 2026-04-23, CollPlant Biotechnologies Ltd (CLGN) has a next-year EPS growth estimate of 69.18%.
On 2026-04-23, analyst consensus for CLGN's next-year EPS growth shifted from 69.24% to 69.18% — a negative change of 0.06 percentage points. Current-year growth is projected at 37.76%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 69.18%
- EPS growth this year
- 37.76%
- EPS next quarter (est)
- -$0.24
- Last price
- $0.36
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-04-23 | 69.18% | 37.76% | -$0.24 | $0.36 |
| 2026-04-22 | 69.24% | 37.76% | -$0.24 | $0.39 |
| 2026-04-21 | 69.24% | 37.76% | -$0.24 | $0.38 |
| 2026-04-20 | 69.24% | 37.76% | -$0.24 | $0.37 |
| 2026-04-19 | 69.24% | 37.76% | -$0.24 | $0.36 |
| 2026-04-16 | 69.24% | 37.76% | -$0.24 | $0.35 |
| 2026-04-15 | 69.24% | 37.76% | -$0.24 | $0.32 |
| 2026-04-14 | 69.24% | 37.76% | -$0.24 | $0.29 |
| 2026-04-13 | 69.49% | 37.23% | -$0.24 | $0.32 |
| 2026-04-12 | 69.49% | 37.23% | -$0.24 | $0.38 |
| 2026-04-10 | 69.49% | 37.23% | -$0.24 | $0.41 |
| 2026-04-09 | 69.49% | 37.23% | -$0.24 | $0.38 |
| 2026-04-08 | 69.49% | N/A | -$0.24 | $0.34 |
| 2026-04-07 | 69.49% | N/A | -$0.24 | $0.36 |
| 2026-04-06 | 69.49% | N/A | -$0.24 | $0.36 |
| 2026-04-05 | 69.49% | N/A | -$0.24 | $0.53 |
| 2026-04-03 | 69.49% | N/A | -$0.24 | $0.36 |
| 2026-04-02 | 69.49% | N/A | -$0.24 | $0.36 |
| 2026-04-01 | 69.49% | N/A | -$0.24 | $0.36 |
| 2026-04-01 | 69.49% | N/A | N/A | $0.53 |
| 2026-04-01 | 69.49% | N/A | N/A | $0.53 |
| 2026-04-01 | 69.49% | N/A | N/A | $0.53 |
| 2026-03-31 | 69.49% | N/A | N/A | $0.54 |
| 2026-03-31 | 69.49% | N/A | N/A | $0.54 |
| 2026-03-31 | 69.49% | N/A | N/A | $0.54 |
| 2026-03-30 | 69.49% | N/A | N/A | $0.59 |
| 2026-03-30 | 69.49% | N/A | N/A | $0.59 |
| 2026-03-30 | 69.49% | N/A | N/A | $0.59 |
| 2026-03-29 | 69.49% | N/A | N/A | $0.62 |
| 2026-03-29 | 69.49% | N/A | N/A | $0.62 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is CollPlant Biotechnologies Ltd's next-year EPS growth estimate?▾
As of 2026-04-23, CollPlant Biotechnologies Ltd (CLGN) has a next-year EPS growth estimate of 69.18%, based on analyst consensus.
When was the latest EPS estimate revision for CLGN?▾
The most recent revision occurred on 2026-04-23, when analysts adjusted the next-year EPS growth estimate from 69.24% to 69.18%.
What sector and industry does CollPlant Biotechnologies Ltd belong to?▾
CollPlant Biotechnologies Ltd operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CLGN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. CollPlant Biotechnologies Ltd (CLGN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports